Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.601122
Title: Development and characterisation of multilayer biomaterials for use in the urinary tract
Author: Croskery, Andrew
Awarding Body: Queen's University Belfast
Current Institution: Queen's University Belfast
Date of Award: 2013
Availability of Full Text:
Full text unavailable from EThOS.
Please contact the current institution’s library for further details.
Abstract:
The use of medical devices in the urinary tract is limited by infection. Consequences of catheter-associated urinary tract infection include an increase in mortality, perhaps due to secondary bacteraemia and septicaemia is, as well as increased expenditure on the replacement of catheters. Infection with urease-producing bacteria such as Proteus mirablis results in hydrolysis of urea in ammonia and carbon dioxide, and precipitation of magnesium and calcium salts which can result in the blockage of urinary medical devices, resulting in urine bypassing the catheter. This thesis aims to present a proof-of-concept of a pH-triggered multilayer catheter coating, capable of reacting to the presence of infection In vivo to reduce bacterial adherence to a urinary biomaterial. The methyl methacrylate polymers, Eudragit Preparation 415SF and Eudragit L1OO, were investigated as potential urinary catheter coatings. Eudragit Preparation 415SF is soluble at pH values above pH 7. Eudragit L lOO is soluble at pH values above pH 6. It was hypothesised that the tell-tale increase in pH as a result of infection with urease-producing bacteria like P. mirabilis would trigger a shedding of these surface layers, reducing bacterial adherence. By loading these polymer coatings with antibacterial agents and functional excipients, active agent could be released into the surrounding area, providing a secondary means of reducing bacterial activity. Initial studies developed formulations of Eudragit Preparation 41SSF and Eudragit L100, loaded with levofloxacin or nalidixic acid as model antibiotics, that could be processed using bench-top hot-melt extruders. Drug release studies in phosphate buffered saline at pH values representative of healthy and infected urine (pH 6.2 and ph. 7.8, respectively) demonstrated the pH-responsive properties of these formulations. When challenged with bacteria in artificial urine, the response of these formulations to the pH change caused by infection with urease-producing bacteria was demonstrated, with significantly reduced bacterial adherence with levofloxacin-containing formulations.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.601122  DOI: Not available
Share: